Changes in brain oxidative metabolism induced by inhibitory avoidance learning and acute administration of amitriptyline

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 3, 2008, Pages 456-462

  González Pardo, Héctor ^a   Conejo, Nélida M ^a   Arias, Jorge L ^a   Monleón, Santiago ^b   Vinader Caerols, Concepción ^b   Parra, Andrés ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Amitriptyline; Cytochrome oxidase; Inhibitory avoidance; Limbic system; Mouse; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; CYTOCHROME C OXIDASE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AVOIDANCE LEARNING; BRAIN; ELECTRON TRANSPORT COMPLEX IV; MALE; MICE; OXIDATION-REDUCTION;

ANIMALIA;

EID: 40849114303     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.01.022     Document Type: Article

References (53)

1. Agin V., Chicher R., and Chichery M.P. Effects of learning on cytochrome oxidase activity in cuttlefish brain. Neuroreport 12 (2001) 113-116
2. Ambrogi Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., and Tassoni G. Neural topography and chronology of memory consolidation: a review of functional inactivation findings. Neurobiol Learn Mem 71 (1999) 1-18
3. Arenas M.C., Vinader-Caerols C., Monleón S., Martos A.J., Everss E., Ferrer-Añó A., et al. Are the effects of the antidepressants amitriptyline, maprotiline, and fluoxetine on inhibitory avoidance state-dependent?. Behav Brain Res 166 (2006) 150-158
4. Barbui C., and Hotopf M. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br J Psychiatry 178 (2001) 129-144
5. Biegon A., and Mathis C. Evaluation of [3H]paroxetine as an in vivo ligand for serotonin uptake sites: a quantitative autoradiographic study in the rat brain. Synapse 13 (1993) 1-9
6. Burt D.B., Zembar M.J., and Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 117 (1995) 285-305
7. Conejo N.M., González-Pardo H., Vallejo G., and Arias J.L. Involvement of the mammillary bodies in spatial working memory revealed by cytochrome oxidase activity. Brain Res 1011 (2004) 107-114
8. Conejo N.M., López M., Cantora R., González-Pardo H., López L., Begega A., et al. Effects of Pavlovian fear conditioning on septohippocampal metabolism in rats. Neurosci Lett 373 (2005) 94-98
9. Conejo N.M., González-Pardo H., Vallejo G., and Arias J.L. Changes in brain oxidative metabolism induced by water maze training. Neuroscience 145 (2007) 403-412
10. Cusack B., Nelson A., and Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 114 (1994) 559-565
11. Deglise P., Dacher M., Dion E., Gauthier M., and Armengaud C. Regional brain variations of cytochrome oxidase staining during olfactory learning in the honeybee (Apis mellifera). Behav Neurosci 117 (2003) 540-547
12. Doyle E., Nolan P.M., and Regan C.M. Learning-induced change in neural activity during acquisition and consolidation of a passive avoidance response in the rat. Neurochem Res 15 (1990) 551-558
13. Everss E., Arenas M.C., Vinader-Caerols C., Monleón S., and Parra A. Piracetam counteracts the effects of amitriptyline on inhibitory avoidance in CD1 mice. Behav Brain Res 159 (2005) 235-242
14. Freo U. Cerebral metabolic effects of serotonin drugs and neurotoxins. Life Sci 59 (1996) 877-891
15. Freo U., Pietrini P., Pizzolato G., Furey M., Merico A., Ruggero S., et al. Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats. Neuropsychopharmacology 13 (1995) 215-222
16. Freo U., Ori C., Dam M., Merico A., and Pizzolato G. Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies. Brain Res 854 (2000) 35-41
17. Gerber III J.C., Choki J., Brunswick D.J., Reivich M., and Frazer A. The effect of antidepressant drugs on regional cerebral glucose utilization in the rat. Brain Res 269 (1983) 319-325
18. González-Lima F., and Jones D. Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal-intensified histochemistry. Brain Res 660 (1994) 34-49
19. González-Lima F., and Cada A. Quantitative histochemistry of cytochrome oxidase activity: theory, methods, and regional brain vulnerability. In: González-Lima F. (Ed). Cytochrome oxidase in neuronal metabolism and Alzheimer's disease (1998), Plenum, New York 55-90
20. González-Pardo H., Conejo N.M., and Arias J.L. Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem. Prog Neuro-psychopharmacol Biol Psychiatry 30 (2006) 1020-1026
21. Hu D., Xu X., and González-Lima F. Vicarious trial-and-error behavior and hippocampal cytochrome oxidase activity during Y-maze discrimination learning in the rat. Int J Neurosci 116 (2006) 265-280
22. Izquierdo L.A., Barros D.M., Vianna M.R., Coitinho A., deDavid e Silva T., Choi H., et al. Molecular pharmacological dissection of short- and long-term memory. Cell Mol Neurobiol 22 (2002) 269-287
23. Izquierdo L.A., and Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 68 (1997) 285-316
24. Jinks A.L., and McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res 772 (1997) 181-190
25. Kerr J.S., Powell J., and Hindmarch I. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 42 (1996) 239-241
26. López L., Lorente L., Arias J., González-Pardo H., Cimadevilla J., and Arias J.L. Changes of cytochrome oxidase activity in rat suprachiasmatic nucleus. Brain Res 769 (1997) 367-371
27. Mann J.J. The medical management of depression. N Engl J Med 353 (2005) 1819-1834
28. Maren S., and Quirk G.J. Neuronal signalling of fear memory. Nat Rev Neurosci 5 (2004) 844-852
29. Martinez I., Quirarte G.L., Diaz-Cintra S., Quiroz C., and Prado-Alcala R.A. Effects of lesions of hippocampal fields CA1 and CA3 on acquisition of inhibitory avoidance. Neuropsychobiology 46 (2002) 97-103
30. Mello e Souza T., Vianna M.R., Rodrigues C., Quevedo J., Moleta B.A., and Izquierdo I. Involvement of the medial precentral prefrontal cortex in memory consolidation for inhibitory avoidance learning in rats. Pharmacol Biochem Behav 66 (2000) 615-622
31. Monleón S., Urquiza A., Arenas M.C., Vinader-Caerols C., and Parra A. Chronic administration of fluoxetine impairs inhibitory avoidance in male but not female mice. Behav Brain Res 136 (2002) 483-488
32. Naudon L., Hotte M., and Jay T.M. Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology 191 (2007) 353-364
33. Overton D.A. Experimental methods for the study of state-dependent learning. Fed Proc 33 (1974) 1800-1813
34. Parra A. A common role for psychotropic medications: memory impairment. Med Hypotheses 60 (2003) 133-142
35. Parra A., Everss E., Monleón S., Vinader-Caerols C., and Arenas M.C. Effects of acute amitriptyline administration on memory, anxiety and activity in male and female mice. Neurosci Res Commun 31 (2002) 135-144
36. Parra A., Everss E., Arenas M.C., Vinader-Caerols C., and Monleón S. Amitriptyline administered after consolidation of inhibitory avoidance does not affect memory retrieval. Psicothema 18 (2006) 514-518
37. Poremba A., Jones D., and González-Lima F. Classical conditioning modifies cytochrome oxidase activity in the auditory system. Eur J Neurosci 10 (1998) 3035-3043
38. Porrino L.J., Miller M., Hedgecock A.A., Thornley C., Matasi J.J., and Davies H.M. Local cerebral metabolic effects of the novel cocaine analog, WF-31: comparisons to fluoxetine. Synapse 27 (1997) 26-35
39. Pratt J.A., Laurie D.J., and McCulloch J. The effects of FG 7142 upon local cerebral glucose utilization suggest overlap between limbic structures important in anxiety and convulsions. Brain Res 475 (1988) 218-231
40. Prince J.A., and Oreland L. Mitochondrial activity in the mapping of functional brain changes in schizophrenia. Restor Neurol Neurosci 12 (1998) 185-193
41. Prince J.A., Yassin M.S., and Oreland L. Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine. Neuropharmacology 36 (1997) 1665-1678
42. Puga F., Barrett D.W., Bastida C.C., and Gonzalez-Lima F. Functional networks underlying latent inhibition learning in the mouse brain. Neuroimage 38 (2007) 171-183
43. Richelson E. Pharmacology of antidepressants-characteristics of the ideal drug. Mayo Clin Proc 69 (1994) 1069-1081
44. Roozendaal B., de Quervain D.J., Ferry B., Setlow B., and McGaugh J.L. Basolateral amygdala-nucleus accumbens interactions in mediating glucocorticoid enhancement of memory consolidation. J Neurosci 21 (2001) 2518-2525
45. Shibata K., and Furukawa T. The mammillary body, a potential site of action of neurotensin in passive avoidance behavior in rats. Brain Res 443 (1988) 117-124
46. Snedecor G.W., and Cochran W.G. Statistical methods (1980), The Iowa State University Press, Ames
47. Tinsley M.R., Quinn J.J., and Fanselow M.S. The role of muscarinic and nicotinic cholinergic neurotransmission in aversive conditioning: comparing Pavlovian fear conditioning and inhibitory avoidance. Learn Mem 11 (2004) 35-42
48. van Laar M.W., Volkerts E.R., Verbaten M.N., Trooster S., van Megen H.J., and Kenemans J.L. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory. Psychopharmacology (Berl) 162 (2002) 351-363
49. Veldhuijzen D.S., Kenemans J.L., van Wijck A.J., Olivier B., Kalkman C.J., and Volkerts E.R. Acute and subchronic effects of amitriptyline on processing capacity in neuropathic pain patients using visual event-related potentials: preliminary findings. Psychopharmacology (Berl) 183 (2006) 462-470
50. Winer B. Statistical principles in experimental design. 2nd ed (1991), McGraw-Hill, New York
51. Wong-Riley M.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12 (1989) 94-101
52. Yau J.L., Olsson T., Morris R.G., Meaney M.J., and Seckl J.R. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience 66 (1995) 571-581
53. Yau J.L., Noble J., Hibberd C., and Seckl J.R. Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus. Neurosci Lett 306 (2001) 161-164